organohalogen compound clonazepam DrugBank:DB01068 5-(2-chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one Beilstein:759557 Patent:US3335181 [O-][N+](=O)c1ccc2NC(=O)CN=C(c3ccccc3Cl)c2c1 5-(2-chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one 315.71100 CAS:1622-61-3 1,3-dihydro-7-nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one 5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one Drug_Central:703 Patent:US3121076 5-(o-chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one KEGG:D00280 315.04107 CHEBI:3756 chebi_ontology CHEBI:102465 Patent:US3116203 PMID:10633040 C15H10ClN3O3 Wikipedia:Clonazepam 0 clonazepam DGBIGWXXNGSACT-UHFFFAOYSA-N PMID:12213069 CLONAZEPAM InChI=1S/C15H10ClN3O3/c16-12-4-2-1-3-10(12)15-11-7-9(19(21)22)5-6-13(11)18-14(20)8-17-15/h1-7H,8H2,(H,18,20) clonazepamum 1,3-Dihydro-2H-1,4-benzodiazepin-2-one in which the hydrogens at positions 5 and 7 are substituted by 2-chlorophenyl and nitro groups, respectively. It is used in the treatment of all types of epilepsy and seizures, as well as myoclonus and associated abnormal movements, and panic disorders. However, its use can be limited by the development of tolerance and by sedation. PMID:12873507